{"url": "http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/", "text": "", "images": ["http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/video/b-roll-for-fda-approval-of-zepatiertm-2-512X288.jpg", "http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/image/zepatiertm-dose-pack-3-RSS.jpg", "http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/image/zepatiertm-tablet-5-512X288.jpg", "http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/image/zepatiertm-11-512X288.jpg", "http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/image/zepatiertm-dose-pack-3-HR.jpg", "http://www.multivu.com/omt-reporting-proxy//extraplayers/heroplayer/images/download-photo-icon.png", "http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/image/logo2-sm-null-HR.jpg", "http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/image/merck-logo-null-HR.jpg", "http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/image/merck-13-512X288.jpg", "http://www.multivu.com/omt-reporting-proxy//extraplayers/heroplayer/images/pinit-photo-icon.png", "http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/image/zepatiertm-tablet-and-dose-pack-4-512X288.jpg", "http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/image/zepatiertm-dose-pack-3-512X288.jpg", "http://www.multivu.com/omt-reporting-proxy//extraplayers/heroplayer/images/embed-photo-icon.png"], "top_img": "http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/image/zepatiertm-dose-pack-3-RSS.jpg", "keywords": [], "authors": ["Multivu - Pr Newswire"], "canonical_link": "http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/", "title": "Merck Receives FDA Approval of ZEPATIER\u2122 (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority Review", "meta_data": {"description": "ZEPATIER Achieves High Cure Rates (SVR12) in Broad Range of Patients with Chronic Hepatitis C Infection, Including Those with Compensated Cirrhosis, Renal Impairment of Any Degree and HIV-1/HCV Co-infection", "author": "MultiVu - PR Newswire", "og": {"title": "Merck Receives FDA Approval of ZEPATIER\u2122 (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority Review", "type": "other", "url": "http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/", "image": "http://www.multivu.com/players/English/7672251-merck-zepatier-fda-approval/image/zepatiertm-dose-pack-3-RSS.jpg", "site_name": "Multivu", "description": "ZEPATIER Achieves High Cure Rates (SVR12) in Broad Range of Patients with Chronic Hepatitis C Infection, Including Those with Compensated Cirrhosis, Renal Impairment of Any Degree and HIV-1/HCV Co-infection"}, "viewport": "width=device-width, initial-scale=1.0"}, "movies": [], "publish_date": null, "source": "http://www.multivu.com", "summary": ""}